Objectives: This study aimed to compare the efficacy of methylphenidate and atomoxetine
on improving executive functions among children with attention-deficit/hyperactivity disorder …

This study aimed to compare the effects of osmotic release oral system-methylphenidate
(OROS-MPH) and atomoxetine (ATX) on executive function in children and adolescents with …

Objectives The aim of this study to compare the clinic efficacy and effects of osmotic release
oral system-methylphenidate and atomoxetine on executive function in children and …

Background This study examined the effects of atomoxetine (ATX) and OROS
methylphenidate (MPH) on laboratory measures of inhibitory control and attention in youth …

Objective: The efficacy of both methylphenidate and atomoxetine has been established in
placebo-controlled trials. The present study aimed to directly compare the efficacy of …

The aim of this study was to compare the safety, efficacy, tolerability, and the effects of
atomoxetine and OROS-MPH on executive functions in children with ADHD. This study was …

Background Methylphenidate may improve executive functioning in children with attention‐
deficit/hyperactivity disorder (ADHD). However, it is unclear if there are still acute effects of …

Objective: The aim of this study was to evaluate and compare the effects of atomoxetine
(ATX) and osmotic release oral system-methylphenidate (OROS-MPH) therapies on …

Atomoxetine is efficacious in reducing symptoms of attention deficit hyperactivity disorder
(ADHD) but its effect on executive functions needs more investigation. We examined the …

Results regarding the effects of methylphenidate and atomoxetine on executive functions
were inconsistent and no study has directly compared the efficacy of these two medications …